import type { BlogArticle } from '../blog-types';

export const article: BlogArticle = {
  slug: "peptide-reconstitution-complete-protocol-jun21-2026",
  title: "How to Reconstitute Peptides: A Complete Research Protocol (2026)",
  description:
    "Step-by-step research protocol for reconstituting lyophilized peptides. Covers diluent selection, concentration calculations, aseptic technique, and storage best practices for pre-clinical research settings.",
  category: "Research Protocols",
  readMinutes: 10,
  publishedAt: "2026-06-21",
  ogImage: "/og-image.jpg",
  body: [
    {
      type: "paragraph",
      text: "Lyophilized peptides — freeze-dried to a stable powder — require reconstitution before use in research applications. Proper reconstitution directly affects peptide stability, accurate dosing, and the integrity of experimental results. This guide outlines the standard protocol used in pre-clinical research settings.",
    },
    {
      type: "heading",
      text: "Why Reconstitution Matters",
    },
    {
      type: "paragraph",
      text: "Peptides in lyophilized form are stable at controlled temperatures for extended periods. Once reconstituted in aqueous solution, they become significantly more vulnerable to hydrolysis (water-mediated peptide bond cleavage), aggregation (formation of non-bioactive molecular clusters), and bacterial contamination — particularly relevant in multi-use vials. Getting reconstitution right means choosing the correct diluent, calculating concentration accurately, and following aseptic technique from start to finish.",
    },
    {
      type: "heading",
      text: "Choosing the Right Diluent",
    },
    {
      type: "subheading",
      text: "Bacteriostatic Water (BW)",
    },
    {
      type: "paragraph",
      text: "Bacteriostatic water — sterile water containing 0.9% benzyl alcohol — is the most commonly used diluent for research peptides. Benzyl alcohol acts as a preservative, inhibiting bacterial growth in multi-use vials. It is recommended for most GHRH analogs and GHSs (CJC-1295, Ipamorelin, Sermorelin), as well as BPC-157, TB-500, PT-141, and any peptide that will be used from a single vial over multiple sessions.",
    },
    {
      type: "subheading",
      text: "Sterile Water for Injection",
    },
    {
      type: "paragraph",
      text: "Plain sterile water (no preservative) is appropriate when the entire vial will be used in a single application, or when the peptide is incompatible with benzyl alcohol — rare but documented for some sequences. Without a bacteriostatic agent, opened vials should be used promptly to minimize contamination risk.",
    },
    {
      type: "subheading",
      text: "0.6% Acetic Acid Solution",
    },
    {
      type: "paragraph",
      text: "Some peptides — particularly hydrophobic sequences or those with poor aqueous solubility — require an acidic diluent for initial dissolution. IGF-1 and some variants of GH-releasing peptides may dissolve more completely in dilute acetic acid. The standard protocol is to dissolve initially in acetic acid, then dilute to the final target concentration with bacteriostatic water or phosphate-buffered saline (PBS).",
    },
    {
      type: "heading",
      text: "Equipment Required",
    },
    {
      type: "list",
      items: [
        "Lyophilized peptide vial",
        "Diluent (bacteriostatic water or appropriate alternative)",
        "Insulin syringe (1 mL, 28–31 gauge) or research-grade syringe",
        "Alcohol swabs (70% isopropyl)",
        "Clean preparation surface",
        "Calculator or concentration reference",
      ],
    },
    {
      type: "heading",
      text: "Step-by-Step Reconstitution Protocol",
    },
    {
      type: "subheading",
      text: "Step 1: Prepare Your Environment",
    },
    {
      type: "paragraph",
      text: "Work in a clean environment. Wipe down the preparation surface with 70% isopropyl alcohol. Wash hands thoroughly or use nitrile gloves. If available, work near a laminar flow hood for added sterility assurance.",
    },
    {
      type: "subheading",
      text: "Step 2: Calculate Your Target Concentration",
    },
    {
      type: "paragraph",
      text: "Determine the concentration needed for your research protocol before adding any liquid. The standard formula: Concentration (mcg/mL) = Peptide mass (mcg) ÷ Volume of diluent (mL). For example, a 5 mg (5,000 mcg) vial reconstituted with 2 mL of bacteriostatic water yields 2,500 mcg/mL. If 250 mcg per administration is needed, each dose requires 0.1 mL (10 units on a standard U-100 insulin syringe).",
    },
    {
      type: "subheading",
      text: "Step 3: Swab the Vial Tops",
    },
    {
      type: "paragraph",
      text: "Clean both the peptide vial septum and the diluent vial septum with a fresh alcohol swab. Allow to air-dry completely before proceeding — wet alcohol can introduce contamination and affect the peptide.",
    },
    {
      type: "subheading",
      text: "Step 4: Draw the Diluent",
    },
    {
      type: "paragraph",
      text: "Draw the calculated volume of diluent into the syringe. Insert the needle through the cleaned septum of the peptide vial, directing it to the side of the vial so the liquid runs down the glass rather than spraying directly onto the lyophilized powder. This gentle technique helps prevent bubble formation and mechanical disruption of the peptide structure.",
    },
    {
      type: "subheading",
      text: "Step 5: Dissolve Without Shaking",
    },
    {
      type: "paragraph",
      text: "Once the diluent is added, gently rotate or swirl the vial until the powder is fully dissolved. Do not shake vigorously — mechanical agitation can cause aggregation and denaturation. Some peptides (particularly those with complex structures) may take several minutes to fully dissolve. If complete dissolution is not achieved, gentle warming to room temperature and slow rotation may assist. A cloudy reconstituted solution may indicate aggregation or improper diluent selection.",
    },
    {
      type: "subheading",
      text: "Step 6: Inspect the Solution",
    },
    {
      type: "paragraph",
      text: "A properly reconstituted research peptide solution should be clear and colorless (or very faintly tinted in some cases). Discard if the solution shows visible particulate matter, significant turbidity after complete dissolution time, unusual coloration, or strong odor. Visual inspection is not a substitute for HPLC verification but catches obvious quality issues.",
    },
    {
      type: "heading",
      text: "Storage After Reconstitution",
    },
    {
      type: "paragraph",
      text: "Reconstituted peptides are significantly less stable than lyophilized forms. Standard storage guidelines for research settings: refrigerate reconstituted peptides at 2–8°C (do not freeze reconstituted solutions, as freeze-thaw cycles accelerate degradation), use reconstituted vials within 28–30 days when bacteriostatic water is used (shorter if plain sterile water), keep vials in the dark during storage, and label all vials with preparation date, concentration, and peptide identity.",
    },
    {
      type: "heading",
      text: "Common Reconstitution Errors",
    },
    {
      type: "list",
      items: [
        "Shaking the vial vigorously — causes aggregation and activity loss",
        "Using the wrong diluent — can cause immediate precipitation for certain sequences",
        "Injecting diluent directly onto the lyophilized powder — mechanical disruption, bubble formation",
        "Failing to swab septum tops — contamination risk",
        "Not calculating concentration before adding liquid — results in inaccurate dosing",
        "Freezing reconstituted solutions — accelerates degradation via ice crystal damage",
      ],
    },
    {
      type: "heading",
      text: "Concentration Reference Table",
    },
    {
      type: "table",
      headers: ["Peptide Amount", "Diluent Added", "Resulting Concentration", "Dose per 0.1 mL"],
      rows: [
        ["5 mg (5,000 mcg)", "1 mL BW", "5,000 mcg/mL", "500 mcg"],
        ["5 mg (5,000 mcg)", "2 mL BW", "2,500 mcg/mL", "250 mcg"],
        ["5 mg (5,000 mcg)", "5 mL BW", "1,000 mcg/mL", "100 mcg"],
        ["2 mg (2,000 mcg)", "1 mL BW", "2,000 mcg/mL", "200 mcg"],
        ["2 mg (2,000 mcg)", "2 mL BW", "1,000 mcg/mL", "100 mcg"],
        ["10 mg (10,000 mcg)", "2 mL BW", "5,000 mcg/mL", "500 mcg"],
      ],
    },
    {
      type: "heading",
      text: "Quality Assurance Notes",
    },
    {
      type: "paragraph",
      text: "Reconstitution technique affects research reproducibility. Documented protocol adherence — including diluent lot numbers, preparation dates, storage conditions, and visual inspection notes — is essential for rigorous pre-clinical research record-keeping. For multi-site research collaborations, standardizing reconstitution protocols ensures comparability across experimental batches.",
    },
    {
      type: "callout",
      text: "All Nexphoria peptides are supplied as lyophilized powders with lot-specific COAs confirming purity and identity prior to reconstitution. HPLC purity ≥99% is verified at synthesis — proper reconstitution technique preserves that purity through to the research bench.",
    },
    {
      type: "disclaimer",
      text: "This article is intended for research and educational purposes only. All compounds referenced are for laboratory research use exclusively and are not approved for human administration. Researchers should comply with all applicable institutional and regulatory guidelines.",
    },
  ],
};
